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Abstract: Healthy aging is associated with cognitive declines typically
accompanied by increased task-related brain activity in comparison to
younger counterparts. The Scaffolding Theory of Aging and Cognition (STAC)
(Park and Reuter-Lorenz, 2009; Reuter-Lorenz and Park, 2014) posits that
compensatory brain processes are responsible for maintaining normal
cognitive performance in older adults, despite accumulation of aging-related
neural damage. Cross-sectional studies indicate that cognitively intact elders
at genetic risk for Alzheimer’s disease (AD) demonstrate patterns of increased
brain activity compared to low risk elders, suggesting that compensation
represents an early response to AD-associated pathology. Whether this
compensatory response persists or declines with the onset of cognitive
impairment can only be addressed using a longitudinal design. The current
prospective, 5-year longitudinal study examined brain activation in APOE ε4
carriers (N=24) and non-carriers (N=21). All participants, ages 65–85 and
cognitively intact at study entry, underwent task-activated fMRI, structural
MRI, and neuropsychological assessments at baseline, 18, and 57 months.
fMRI activation was measured in response to a semantic memory task
requiring participants to discriminate famous from non-famous names.
Results indicated that the trajectory of change in brain activation while
performing this semantic memory task differed between APOE ε4 carriers and
non-carriers. The APOE ε4 group exhibited greater activation than the Low
Risk group at baseline, but they subsequently showed a progressive decline in
activation during the follow-up periods with corresponding emergence of
episodic memory loss and hippocampal atrophy. In contrast, the non-carriers
demonstrated a gradual increase in activation over the 5-year period. Our
results are consistent with the STAC model by demonstrating that
compensation varies with the severity of underlying neural damage and can
be exhausted with the onset of cognitive symptoms and increased structural
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brain pathology. Our fMRI results could not be attributed to changes in task
performance, group differences in cerebral perfusion, or regional cortical
atrophy.
Keywords: Aging, Alzheimer’s disease, APOE ε4, fMRI, Semantic memory

Introduction
Healthy aging is associated with mild and gradual declines in
cognition functions, with the greatest aging-related changes involving
memory, processing speed, and visuospatial skills (Salthouse, 2010).
Such changes often occur in parallel with age-related alterations in
brain structure, characterized by cortical atrophy and white matter
abnormalities (Drachman, 2006; Kramer et al., 2007). Paradoxically,
fMRI studies have consistently found increased regional brain activity
in healthy elders relative to their younger counterparts during the
performance of a cognitive task. This increased task-related brain
activity in healthy elders typically occurs in brain regions also activated
by younger participants, but can also be observed in homologous
regions in the opposite hemisphere (Cabeza et al., 2002; Nielson et
al., 2002, 2006). Some investigators have noted that age-related
increases in brain activity occur most often in the frontal cortex; for
reviews and discussion, see (Buckner, 2004; Eyler et al., 2011;
Nielson et al., 2002). This increased neural activity is thought to serve
as a compensatory function to support a high level of performance in
older adults (Bangen et al., 2012; Carp et al., 2010; Grady, 2008; Han
et al., 2009; Nielson et al., 2002, 2006; Prvulovic et al., 2005; ReuterLorenz and Cappell, 2008; Wierenga et al., 2008).
One prominent theory, the Scaffolding Theory of Aging and
Cognition (STAC) (Park and Reuter-Lorenz, 2009), posits that
compensatory brain processes are responsible for preserving cognitive
performance in older adults, despite accumulation of neural changes in
the context of healthy aging (e.g., mild white matter disease, agerelated atrophy). This theory identifies neural factors that contribute to
maintenance of a specific level of cognitive function and does not
address dynamic longitudinal changes occurring during the aging
process. More recently, these authors (Reuter-Lorenz and Park, 2014)
revised the STAC theory (STAC-r) to account for both positive (e.g.,
physical activity) and negative (e.g., presence of brain amyloid)
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factors that contribute to the rate of change in cognitive function
during aging. This revision provides a framework for tracking the
trajectory of neural compensation (scaffolding) in response to rate of
change in cognitive processes, but empirical validation of the theory is
dependent on imaging data derived from extended longitudinal
imaging studies.
In the current prospective, 5-year longitudinal fMRI study, we
examined compensatory neural scaffolding processes in cognitively
intact elders at varying genetic risk for developing Alzheimer’s disease
(AD). The most important genetic risk factor for the sporadic form of
AD (onset occurring after age 65) is the apolipoprotein E epsilon 4
(APOE ε4) allele (Farrer et al., 1997). Cross-sectional fMRI studies
from our group (Seidenberg et al., 2009; Smith et al., 2011; Woodard
et al., 2009, 2010) and others (Bookheimer et al., 2000; Borghesani
et al., 2008; Filippini et al., 2011; Han et al., 2007; Trachtenberg et
al., 2012; Wierenga and Bondi, 2007; Wierenga et al., 2010) have
consistently demonstrated greater brain activation (neural scaffolding)
in cognitively intact elders at higher genetic risk for AD (based on the
presence of one or both APOE ε4 alleles and/or a family history of AD)
than elders at lower genetic risk. Presumably, this increased activation
occurs because the neuropathological changes associated with AD
begin years or decades prior to symptom manifestation in persons at
genetic risk for AD (Bateman et al., 2012; Jack et al., 2010). Indeed,
alterations in task-related brain activity and cognitive performance
have been reported in cross-sectional studies of APOE-ε4 positive
individuals beginning in middle age and earlier (Evans et al., 2014;
Reiman et al., 2004).
For this study, we recruited cognitively intact elders, APOE ε4
carriers and non-carriers, who underwent repeat cognitive testing,
structural MRI, and task-activated fMRI on three occasions: study
entry, 18 and 57 months. The fMRI task consisted of the Famous
Name Recognition Task (FNRT) (Douville et al., 2005), a low-effort
semantic memory task. The FNRT is performed with high accuracy
even in patients with amnestic mild cognitive impairment (Woodard et
al., 2009), thus removing high effort/low accuracy from complicating
the interpretation of the longitudinal brain maps (Kennedy et al.,
2014). Previous cross-sectional studies (Nielson et al., 2006, 2010;
Seidenberg et al., 2009; Woodard et al., 2010) using this task have
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demonstrated a highly reproducible pattern of brain activation in
regions that overlap with regions that comprise the “default-mode
network” (Nielson et al., 2010; Sugarman et al., 2012).
Based on the STAC-r model, we hypothesized that the
cognitively intact APOE ε4 carriers would exhibit greater task-related
brain activation than non-carriers at study entry, presumably reflecting
a compensatory response that may signal subsequent cognitive decline
(Miller et al., 2008). Over time, however, a breakdown of neural
scaffolding in the APOE ε4 carrier group is predicted to occur,
characterized by the presence of age-inappropriate cognitive
impairment. Decreased brain activity occurs in association with
increased AD-related neural pathology (O’Brien et al., 2010) and is
predicted to coincide with decreased episodic memory performance.
Conversely, non-carriers, who maintain intact and stable episodic
memory over the course of the 5 year follow-up period, should show a
steady increase in brain activation reflecting the increasing demands of
their scaffolding system to maintain memory performance with
advancing age.

Material and methods
Participants
This study was approved by the Institutional Review Board of
the Medical College of Wisconsin, which oversees the ethical standards
of human research. Written informed consent was obtained from all
subjects included in this study. All participants received financial
compensation.
The recruitment strategy for this study, described in detail in
Seidenberg et al. (2009), involved over-sampling persons at genetic
risk for AD based on the presence of an APOE ε4 allele. Briefly, healthy
older adults between the ages of 65 and 85 were recruited from
newspaper advertisements. A telephone screen, used to determine
study eligibility, was administered to 459 individuals. Participants were
excluded if they reported a history of neurological disease, medical
illnesses, major psychiatric disturbance meeting DSM-IV Axis I criteria,
a Geriatric Depression Scale [GDS; (Yesavage et al., 1982)] score
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>20, Lawton Instrumental Activities of Daily Living [IADL; (Lawton and
Brody, 1969)] scale <5, substance abuse meeting DSM-IV Axis I
criteria, or were currently taking psychoactive medications. Additional
exclusion criteria related to fMRI scanning included pregnancy, weight
inappropriate for height, ferrous objects within the body, low visual
acuity, and a history of claustrophobia. For purposes of fMRI scanning,
only right-handed participants were included based on the Edinburgh
Handedness Inventory (Oldfield, 1971). Of the individuals meeting
inclusion/exclusion eligibility criteria, 109 agreed to undergo APOE
genotype testing from blood samples, neuropsychological evaluation,
and an fMRI scanning session. APOE genotype was determined using a
polymerase chain reaction method. DNA was isolated with Gentra
Systems Autopure LS for Large Sample Nucleic Acid Purification
(O’Brien et al., 2001). Of the 109 enrolled participants, we excluded
31 participants with a family history of AD but without an APOE ε4
allele.
Of the remaining 78 participants, 33 were excluded because
they were unable to complete all three testing sessions (baseline, 18,
and 57 months) due to the following reasons: death (6), lost to followup (4), moved away (3), refusal (6), medical contraindications for MR
scanning (6), MR scanner upgrade at 57months preventing comparison
with baseline and 18-month scans (7), and motion corruption of MR
scan (1). The final sample consisted of 45 participants divided into two
groups: 1) APOE ε4 group (n = 24; mean age = 72.5 years. [SD =
4.1]; mean education = 15.7 years. [SD = 3.2]; 19 females [79%])
who were carriers of one or both ε4 alleles (22 ε3/ε4; 2 ε4/ε4) and 2)
Low Risk group (n = 21; mean age = 73.2 years. [SD = 5.3]; mean
education = 14.1 year. [SD = 1.8]; 17 females [81%]) who did not
possess an APOE ε4 allele (1 ε2/ε3; 20 ε3/ε3). In the APOE ε4 group,
17 participants (70.8%) had a family history of dementia, while no
participant in the Low Risk group had a family history of dementia. No
significant group differences were observed for age or gender; a
significant group difference in education, reflecting more years of
education in the APOE ε4 group, was observed (p= 0.04).
For each session, neuropsychological testing and MR scanning
were conducted on the same day. Participants were asked to refrain
from alcohol use 24 h and caffeine use 12 h prior to testing. The
neuropsychological test battery consisted of the Mini-Mental State
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Examination (Folstein et al., 1975), Mattis Dementia Rating Scale 2
[DRS-2; (Jurica et al., 2001)], and Rey Auditory Verbal Learning Test
[RAVLT; (Rey, 1958)]. Alternate, equivalent test forms were used at
each session to minimize practice effects.
Participants were evaluated for the presence of Mild Cognitive
Impairment (MCI) or AD at the two follow-up sessions. The diagnosis
of MCI and AD was based on a multidisciplinary consensus conference
that reviewed each participant’s medical history and social history
since the previous examination, cognitive test results, and activities of
daily living competency. Each participant was queried regarding
cognitive complaints (e.g., memory, planning ability, attention,
language). If a complaint was expressed, performance on the DRS-2
and RAVLT was compared to an age-adjusted normative database;
scores 1.5 SD below the mean on one or more subscales indicated
MCI, as long as no functional impairment was reported on the IADL
scale. If IADL scores were in the abnormal range (<5), a diagnosis of
AD was made. No participant met the criteria for AD during the study
period.

Imaging
MRI acquisition
Whole-brain, event-related fMRI was conducted on a General
Electric (Waukesha, WI) Signa Excite 3.0 Tesla short bore scanner
equipped with a quad split quadrature transmit/receive head coil.
Echoplanar images were collected using an echoplanar pulse sequence
(TE = 25 ms; flip angle = 77°; field of view (FOV) = 24 mm; matrix
size = 64 × 64). Thirty-six contiguous axial 4-mm-thick slices were
selected to provide coverage of the entire brain (voxel size = 3.75 ×
3.75 × 4 mm). The interscan interval (TR) was 2 s.
High-resolution, three-dimensional spoiled gradient-recalled at
steady-state (SPGR) anatomic images were acquired (TE = 3.9 ms; TR
= 9.5 ms; inversion recovery (IR) preparation time = 450 ms; flip
angle = 12°; number of excitations (NEX) = 2; slice thickness = 1.0
mm; FOV = 24 cm; resolution = 256 × 224).
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Perfusion images were collected at the 57 month follow-up using
pseudocontinuous ASL (pCASL) (Dai et al., 2008), using an echoplanar
pulse sequence (flip angle=90°; field of view (FOV)=240mm; matrix
size = 64 × 64). Scans were collected as two volumes (inferior and
superior), each consisting of 12 axial 5-mm-thick slices (+1 mm skip),
selected to provide whole brain coverage (voxel size = 3.75 × 3.75 ×
4mm, TR=4 s, reps=90). In order to register the two volumes, a
whole brain image of 24 slices was acquired (slices = 24, TR = 4 s,
reps = 6). Foam padding was used to reduce head movement within
the coil.

fMRI task
The task stimuli consisted of 30 names of famous persons and
30 names of unfamiliar individuals selected from an original pool of
784 names because of a high rate of identification (>90% correct;
(Douville et al., 2005)). A trial consisted of the visual presentation of a
single name for 4 s. Participants were instructed to make a right index
finger key press if the name was famous and a right middle finger key
press if the name was not famous. The 60 name trials were randomly
interspersed with 30 4-sec. trials in which the participant was
instructed to fixate on a single centrally placed crosshair. This
condition was performed in order to introduce “jitter” into the fMRI
time course. The imaging run began and ended with 12 s of fixation.
Total time for the single imaging run was 5 min and 24 s.
Accuracy (% correct) and reaction time (RT) were recorded for
identification of Famous Names and rejection of Non-Famous Names.
In addition, a signal detection index of discriminability (d′) (Aaronson
and Watts, 1987; Grier, 1971) was calculated along with a measure of
intraindividual variability (IIV) calculated from the standard deviation
of the Famous and Non-Famous RTs for each participant and time
interval.

fMRI image analysis
Functional images were generated with the Analysis of
Functional NeuroImages (AFNI) software package (Cox, 1996). fMRI
time series data were time-shifted to coincide with the beginning of
the TR, motion corrected, transformed to Talairach space, normalized
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to a whole brain average signal of 10,000, and Gaussian spatial
filtered to 6 mm FWHM.
The hemodynamic response (HDR) was deconvolved using
ordinary least squares regression with an impulse response model
from stimulus onset to 16 s post-stimulus-onset, using regressors for
three types of trials: famous names correct, non-famous names
correct, and incorrect. Hemodynamic responses were shifted so that
stimulus onset was 0. The unfamiliar names’ HDR was subtracted from
the famous names’ HDR. The Famous-Non-Famous contrast was
summarized by summing the points at 4, 6 and 8 s post-stimulusonset (peak of the HDR curve).
The first phase of the fMRI analysis examined the spatial extent
of neural activation with voxelwise t-tests performed on the FamousNon-Famous Names subtraction for each group at each session. A
voxel was deemed “active” with the following threshold: individual
voxel p < 0.005 and minimum cluster volume >0.731 ml. These
values were determined from a Monte Carlo simulation producing a
familywise error of identifying a significant cluster at p < 0.05 (Cox,
1996).
The second analytic phase involved the identification of
functional regions of interest (fROI). A disjunction mask was derived
from the voxelwise maps generated in the previous phase. Any voxel
deemed “significant” in any of the groups and at any of the scan
sessions was included in the fROI map. For each participant and time
period, the fMRI signal change was averaged across voxels within each
fROI.
The resulting longitudinal fROI data were fit to a linear mixed
effects (LME) model using R version number 3.0.2 (Team, 2008). LME
modeling has a number of advantages over a traditional repeated
measures analysis of variance (ANOVA) (Singer and Willett, 2003).
First, LME permits the modeling of the actual time intervals between
repeated assessments, whereas repeated measures ANOVA assumes
equal intervals between evaluations. In this study, our intervals
between evaluations were 18 and 57 months, necessitating the use of
an analytic technique that can model these unequally spaced time
intervals. Furthermore, LME permits the use of the actual number of
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days between scans as the time variable for individual subjects.
Second, LME permits an unequal number of within-subject
observations, making this technique quite flexible in cases where
missing data may occur. In contrast, repeated measures ANOVA
requires all participants to have observations at each measurement
point. If a participant has a single missing data point, that participant
could not be included in the repeated measures analysis.
The level one random effects model for this analysis consisted of
a linear within-subject model of fMRI activation as a function of weeks
post baseline. The level two fixed effects model estimated the slope
and intercept of fMRI activation across groups and weeks post
baseline, where the Low Risk group provided the base model and the
APOE ε4 group differences were modeled with respect to the Low Risk
group. Residuals were visually inspected using quantile–quantile plots
to confirm the assumption of normality. A quadratic model was also
considered, but comparison of the Akaike Information Criterion (AIC)
for each model showed that the linear model was preferred.

Perfusion IMAGING
AFNI was used to process the perfusion data. Each subject’s
whole brain perfusion image was aligned to the fMRI data. After
discarding the first four images, each of the two perfusion volumes
was corrected for head motion. For each tagged image in the time
series, the preceding and subsequent untagged images were
averaged, and this control image was subtracted from its respective
tagged image. All volumes in the tagged-control time series were
averaged (t-c), as were all volumes in the control time series (c).
Voxelwise blood flow was calculated using Eq. (1) in Wang et al.
(2005), with duration of labeling pulse = 1.5 s, post-labeling delay
time=1 s and tagging efficiency=0.95. To obtain whole brain voxelwise
blood flow data, each of the two volumes was aligned to the realigned
whole brain volume and combined, using average values for any
overlapping voxels, and transformed to Talairach space. Average blood
flow for each of the fROIs was extracted, and each region for the two
groups was compared using a two-sample Welch’s t-test.
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Hippocampal volume
The left and right hippocampal volumes were measured from
T1-weighted SPGR images using longitudinal Free surfer v.5.1 (Reuter
et al., 2012) applied to all three scan sessions. No significant
differences were observed between the left and right hippocampal
volumes, so they were summed to create a single bilateral volume,
which was normalized by dividing by the total intracranial volume.

Cortical thickness
Volume-defined cortical fROIs (see fMRI Image Analysis section)
were projected onto the longitudinal Free surfer surfaces for each
subject and scan session Mean cortical thickness was extracted for
each of the fROIs on the cortical surface
(https://surfer.nmr.mgh.harvard.edu/fswiki/VolumeRoiCorticalThickne
ss). ROI cortical thickness measurements were subjected to the
identical LME analysis as applied to the fMRI data.

Results
No group differences were observed in the time interval (in
months) between the baseline and second session (Low Risk = 18.4,
SD = 1.7; APOE ε4=18.2, SD=0.6) and between the baseline and the
third session (Low Risk=58.0, SD=2.1; APOE ε4=56.4, SD=4.3). No
significant group differences were observed for baseline
neuropsychological testing, fMRI task performance, or hippocampal
volume (Table 1).
Table 1. Baseline characteristics of Low Risk and APOE ε4 groups.
Variable
MMSE

Low Risk (n = 21)

APOE e4 (n = 24) p*

Cohen’s d

29.21 (0.98)

0.78

0.08

24.29 (0.96)

24.04 (1.60)

0.53

0.18

141.05 (1.99)

140.33 (3.60)

0.41

0.24

9.90 (2.14)

9.75 (2.92)

0.84

0.06

49.33 (8.39)

48.50 (8.17)

0.74

0.10

Famous (% correct)

93.97 (5.23)

91.39 (7.54)

0.19

0.39

Non-famous (% correct)

95.87 (5.76)

97.78 (3.63)

0.20

−0.40

d′

3.29 (0.64)

3.32 (0.62)

0.85

−0.06

Famous (RT, msec)

1236 (180)

1249 (151)

0.81

−0.07

Non-famous (RT, msec)

1622 (354)

1578 (358)

0.68

0.13

DRS-2 memory
DRS-2 total
RAVLT delayed recall
RAVLT trials 1–5

29.29 (0.85)

**

fMRI task
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Variable
IIV famous (RT)
IIV non-famous (RT)
Hippocampal volume (% ICV)

Low Risk (n = 21)

APOE e4 (n = 24) p*

Cohen’s d

351 (90)

371 (131)

0.57

−0.17

347 (101)

330 (94)

0.56

0.18

0.47 (0.06)

0.46 (0.07)

0.63

0.14

MMSE = Mini Mental State Examination; DRS-2 = Dementia Rating Scale-2; RAVLT =
Rey Auditory Verbal Learning Test; RT = reaction time; IIV= intraindividual variability
based on the average standard deviation of RTs for correct responses; % ICV =
percent intracranial volume.
*p-Values derived from Student t-test, except for gender (Fischer’s exact test).
**Mean (standard deviation).

Table 2 summarizes LME analysis applied to neuropsychological
testing, fMRI task performance, and hippocampal volume. No
significant differences in the intercept (baseline) were observed
between the Low Risk and APOE ε4 groups on these variables.
Likewise, no changes over time (slope) were observed in
neuropsychological testing, fMRI task performance, or hippocampal
volume in the Low Risk group with the exception of a reduction in RT
for the Non-Famous Names condition. Significant differences in slope
were detected in the APOE ε4 group relative to the Low Risk group for
a measure of episodic memory (RAVLT Delayed Recall) and
hippocampal volume, with a pronounced decline observed in the APOE
ε4 group over time (Fig. 1). No other differences in slope were
detected between the Low Risk and APOE ε4 groups. Performance on
the fMRI task remained above 88% correct for all groups and sessions
(chance = 50%).

Fig. 1. Longitudinal changes in RAVLT Delayed Recall (left) and ICV-corrected
hippocampal volume (right) for the Low Risk and APOE ε4 groups at baseline (0
months), 18 months, and 57 months.
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Table 2. Coefficients from linear mixed effects analysis of neuropsychological
test scores, fMRI task performance, and hippocampal volume.
Intercept (baseline)

Variable

Low Riska

Slope (time)

APOE ε4 vs. Low
Riskb

Low Riskc

APOE ε4 vs. Low
Riskd

MMSE

29.35
(0.18)

0.014 (0.246)

0.004 (.007)

−0.014 (.009)

DRS-2 memory

24.30
(0.27)

−0.597 (0.367)

0.008 (.008)

−0.019 (.011)

140.19
(0.58)

−0.717 (0.790)

0.007 (.016)

−0.019 (.022)

9.63 (0.56)

−0.397 (0.770)

0.006 (.011)

−0.036 (.015)

48.84
(1.71)

−1.515 (2.339)

−0.005 (.032)

−0.028 (.044)

94.46
(1.27)

−2.479 (1.738)

−0.099
(0.054)

0.026 (0.074)

96.91
(1.09)

1.456 (1.498)

−0.113
(0.071)

−0.030 (0.097)

3.38 (0.12)

−0.011 (0.162)

−0.007
(0.005)

−0.003 (0.006)

1248.0
(36.0)

−0.893 (49.339)

−1.034
(0.757)

1.688 (1.046)

−3.425
(1.675)

3.997 (2.304)

DRS-2 total
RAVLT delayed recall
RAVLT trials 1–5
fMRI task
Famous (% correct)
Non-famous (%
correct)
d′
Famous (RT, msec)
Non-famous (RT,
msec)

1628.1 −46.960 (101.430)
(74.1)

IIV famous (RT,
msec)

353.4
(23.0)

10.622 (31.475)

−0.237
(0.408)

0.532 (0.564)

IIV non-famous (RT,
msec)

338.3
(21.4)

−5.952 (29.308)

−0.438
(0.593)

1.394 (0.817)

−0.0001
(0.0001)

−0.0003 (0.0001)

Hippocampal volume (% 0.47 (0.01) −0.0100 (0.0203)
ICV)

Bolded values are statistically significant at p < 0.05.
MMSE=MiniMental State Examination; DRS-2=Dementia Rating Scale-2; RAVLT=Rey
Auditory Verbal Learning Test; RT=reaction time; IIV=intraindivual variability based
on the average standard deviation of RTs for correct responses; % ICV = percent
intracranial volume.
aPredicted mean intercept (baseline) value of each dependent variable for the Low Risk
group. All values are statistically significant from 0.
bPredicted difference between mean intercept (baseline) values for the Low Risk group
and the APOE ε4 group.
cPredicted average monthly rate of change (slope) for the Low Risk group.
dPredicted difference in the average monthly rate of change (slope) between the Low
Risk group and the APOE ε4 group. Standard errors of coefficients are in parentheses.

Fig. 2 presents the results of the voxelwise analysis
demonstrating changes in spatial extent of activation for the two
groups over the three sessions. This figure demonstrates a pattern of
increasing spatial extent of activation in the Low Risk group over time
and decreasing spatial extent in the APOE ε4 group.
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Fig. 2. Voxelwise subtraction of the Famous and Non-Famous Name hemodynamic
response functions for the Low Risk and APOE ε4 groups at baseline (0 months), 18
months, and 57 months.

To test this observation, a fROI disjunction mask was created
from the voxelwise analysis (see Materials and methods section) and
resulted in 16 regions shown in Fig. 3. Table 3 summarizes the LME
analysis applied to the 16 fROIs. Intercept analysis indicated that the
APOE ε4 group demonstrated greater activation at baseline than the
Low Risk group in 10 of 16 fROIs. The Low Risk group demonstrated a
significant increase in activation over time (slope) in 4 fROIs. The
APOE ε4 group demonstrated a significant decline over time (slope)
relative to the Low Risk group in 10 of 16 fROIs. Fig. 4 plots the
longitudinal activation changes in these 10 regions. A crossover in
activation was observed, characterized by greater activation of the
APOE ε4 group relative to the Low Risk group at baseline that
subsequently declined over time. In contrast, activation in the Low
Risk group was lower than the APOE ε4 group at baseline but gradually
increased over time.
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Fig. 3. Functional regions of interest (fROIs) generated from a disjunction mask
derived from the Low Risk and APOE ε4 groups at baseline (0 months), 18 months,
and 57 months (see Methods). fROI region numbers correspond to numbers in Tables
3–5. BA= Brodmann’s areas; R= right, L= left, B = bilateral; SMA = supplementary
motor area.
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Fig. 4. Percent MR signal intensity derived from subtraction of Famous and NonFamous Names for 10 fROIs demonstrating significant differences between the Low
Risk and APOE ε4 groups in slope (see Table 3). Numbers in brackets correspond to
fROIs described in Fig. 3.

Table 3. Coefficients from linear mixed effects analysis of functional ROIs
from famous name recognition task.
Intercept (baseline)

No. Side Region

Low Risk

a

APOE ε4 vs
Low Risk b

Slope (time)
Low Risk

c

APOE ε4 vs
Low Risk d

1

B

Precuneus, posterior
cingulate cortex

0.2610
(0.0828)

0.2537
(0.1135)

0.0029
(0.0024)

−0.0078
(0.0033)

2

L

Middle temporal, angular
gyri

0.2381
(0.0552)

0.1839
(0.0756)

0.0012
(0.0016)

−0.0061
(0.0022)

3

R

Middle temporal, angular
gyri

0.0875
(0.0520)

0.2360
(0.0712)

0.0030
(0.0014)

−0.0066
(0.0020)

4

L

Middle, superior frontal
gyri

0.2299
(0.0575)

0.1063
(0.0788)

−0.0002
(0.0017)

−0.0041
(0.0024)

5

L

Inferior & middle
occipital, fusiform gyri

−0.2994
(0.0586)

0.2578
(0.0802)

0.0071
(0.0017)

−0.0090
(0.0024)
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Intercept (baseline)

No. Side Region
6

L

Caudate nucleus

7

R

8
9

Low Risk

a

APOE ε4 vs
Low Risk b

Slope (time)
Low Risk

c

APOE ε4 vs
Low Risk d

0.0448
(0.0661)

0.3274
(0.0905)

0.0027
(0.0021)

−0.0080
(0.0029)

Superior medial gyrus,
SMA

−0.3366
(0.0638)

0.1339
(0.0874)

0.0033
(0.0020)

−0.0027
(0.0027)

R

Superior occipital gyrus

−0.2401
(0.0638)

0.2303
(0.0875)

0.0037
(0.0018)

−0.0037
(0.0025)

R

Inferior occipital gyrus

−0.2962
(0.0565)

0.3126
(0.0773)

0.0055
(0.0017)

−0.0086
(0.0023)

10 R

Fusiform, lingual gyri

−0.1653
(0.0811)

0.5732
(0.1111)

0.0081
(0.0026)

−0.0160
(0.0035)

11 L

Fusiform, lingual gyri

−0.3607
(0.0836)

0.5036
(0.1145)

0.0107
(0.0025)

−0.0145
(0.0035)

12 L

Cerebellum (VII–VIII)

−0.00844
(0.0843)

0.4364
(0.1154)

0.0041
(0.0024)

−0.0128
(0.0033)

13 L

Superior medial gyrus,
anterior cingulate

0.3442
(0.1038)

0.0979
(0.1422)

−0.0009
(0.0028)

−0.0044
(0.0038)

14 R

Hippocampus

0.0990
(0.0708)

0.2039
(0.0970)

0.0030
(0.0020)

−0.0082
(0.0027)

15 L

Hippocampus

0.3171
(0.1064)

−0.0314
(0.1458)

0.0003
(0.0032)

−0.0017
(0.0044)

16 L

Parahippocampal,
fusiform gyri

0.1142
(0.1156)

0.3340
(0.1584)

0.0047
(0.0034)

−0.0089
(0.0047)

Bolded values are statistically significant after control for multiple comparisons using
false discovery rate. SMA = supplementary motor area.
aPredicted mean intercept (baseline) value of each dependent variable for the Low Risk
group.
bPredicted difference between mean intercept (baseline) values for the Low Risk group
and the APOE ε4 group.
cPredicted average monthly rate of change (slope) for the Low Risk group.
dPredicted difference in the average monthly rate of change (slope) between the Low
Risk group and the APOE ε4 group. Values are percent signal change.

No participant was diagnosed with AD or any other form of
dementia over the course of the study. At the 57-month follow-up, 8
of 24 APOE ε4 carriers (33.3%) converted to MCI, whereas only one
noncarrier (4.8%)was diagnosed with MCI. This group difference was
statistically significant (Fisher’s exact test, p = 0.027).
In light of the higher rate of conversion to MCI in the APOE ε4
group, it is conceivable that the decrease in brain activation pattern in
this group was due to cortical atrophy. Table 4 summarizes the LME
analysis applied to 13 cortical fROIs. The Low Risk group demonstrated
an increase in cortical thickness in three fROIs over time. Importantly,
the rate of change in cortical thickness was not different between the
APOE ε4 carrier and non-carrier groups.
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Table 4. Coefficients from linear mixed effects analysis of cortical thickness in
functional ROIs.
Intercept (baseline)
o. Side Region

Low
Risk a

APOE ε4 vs.
Low Risk b

Slope (time)
Low Risk

c

APOE ε4 vs.
Low Risk d

1

B

Precuneus, posterior
cingulate cortex

2.532 0.0434 (.0331)
(.024)

0.0006
(.0003)

−0.0004 (.0004)

2

L

Middle temporal, angular
gyri

2.502 0.0223 (.0378)
(.028)

−0.0003
(.0003)

−0.0008 (.0004)

3

R

Middle temporal, angular
gyri

2.490 0.0524 (.0408)
(.030)

−0.0001
(.0003)

−0.0009 (.0004)

4

L

Middle, superior frontal gyri

2.349 0.0297 (.0469)
(.034)

0.0012
(.0005)

−0.0009 (.0007)

5

L

Inferior & middle occipital,
fusiform gyri

1.976 0.0223 (.0460)
(.033)

0.0006
(.0004)

−0.0006 (.0006)

7

R

Superior medial gyrus, SMA

2.649 0.0413 (.0475)
(.040)

0.0007
(.0004)

−0.0004 (.0006)

8

R

Superior occipital gyrus

2.014 0.0413 (.0475)
(.035)

0.0003
(.0004)

−0.0006 (.0006)

9

R

Inferior occipital gyrus

1.99 0.0346 (.0599)
(.044)

0.0005
(.0005)

−0.0002 (.0007)

10 R

Fusiform, lingual gyri

2.064 0.0591 (.0555)
(.041)

0.0011
(.0004)

−0.0016 (.0006)

11 L

Fusiform, lingual gyri

2.136 −0.0112 (.0583)
(.043)

0.0015
(.0005)

−0.0013 (.0007)

13 L

Superior medial gyrus,
anterior cingulate

2.517 0.2154 (.1125)
(.082)

0.0028
(.0009)

−0.0032 (.0011)

16 L

Parahippocampal, fusiform
gyri

2.296 0.1826 (.1165)
(.085)

0.0007
(.0008)

−0.0014 (.0011)

Standard errors of coefficients are in parentheses.
Bolded values are statistically significant after control for multiple comparisons using
false discovery rate.
aPredicted mean intercept (baseline) value of each dependent variable for the Low Risk
group. Though these values are statistically significant, they’re not indicated in bold
text.
bPredicted difference between mean intercept (baseline) values for the Low Risk group
and the APOE ε4 group.
cPredicted average monthly rate of change (slope) for the Low Risk group.
dPredicted difference in the average monthly rate of change (slope) between the Low
Risk group and the APOE ε4 group. Unless otherwise specified, values are cortical
thickness in millimeters.

The fMRI results could be affected by changes in neurovascular
coupling associated with AD pathology, presumed to be greater in
APOE ε4 carriers. Resting cerebral blood flow was measured using ASL
in the 16 fROIs during the 57-month follow-up session. Table 5
indicates that there were no significant differences in blood flow
between the Low Risk and APOE ε4 groups for any of the fROIs.
Furthermore, resting blood flow did not correlate with fMRI activation
in any of the fROIs after correction for multiple comparisons.
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Table 5. Arterial spin labeling measurements of blood flow conducted at 57month follow-up.
Blood flow

Correlation of fMRI activation
with blood flow
Low Risk

Side Region

Low
Risk

APOE
ε4

p*

Cohen’ **
r
sd

APOE ε4

p

r**

p

1 B

Precuneus,
31.16
30.20 0.6 0.10
posterior
(13.50)** (9.58) 9
cingulate cortex *

0.00

0.98

−0.13

0.26

2 L

Middle
temporal,
angular gyri

25.87
(8.68)

25.43 0.7 0.09
(8.34) 2

−0.02

0.90

−0.14

0.24

3 R

Middle
temporal,
angular gyri

30.89
(13.14)

28.75 0.3 0.22
(8.18) 7

−0.09

0.48

0.00

1.00

4 L

Middle, superior 20.57
frontal gyri
(10.08)

20.25 0.8 0.05
(10.00 5
)

−0.15

0.26

0.01

0.90

5 L

Inferior &
14.66
middle occipital, (7.77)
fusiform gyri

13.09 0.4 0.20
(7.59) 4

0.08

0.55

−0.08

0.51

6 L

Caudate nucleus 19.74
(8.15)

17.56 0.3 0.21
(5.27) 7

−0.18

0.16

0.16

0.17

7 R

Superior medial 21.42
gyrus, SMA
(8.87)

23.02 0.5 0.16
(7.66) 3

−0.24

0.06

0.07

0.54

8 R

Superior
occipital gyrus

20.12
(12.46)

18.80 0.6 0.13
(9.36) 2

−0.03

0.80

−0.05

0.65

9 R

Inferior occipital 20.18
gyrus
(20.18)

15.86 0.3 0.24
(10.99 4
)

0.01

0.92

−0.24

0.04

1 R
0

Fusiform,
lingual gyri

27.15
(11.84)

25.34 0.6 0.15
(13.90 2
)

0.17

0.18

0.10

0.38

1 L
1

Fusiform,
lingual gyri

25.22
(14.03)

23.45 0.4 0.19
(11.67 8
)

−0.02

0.86

0.03

0.79

1 L
2

Cerebellum
(VII–VIII)

12.32
(17.51)

9.10
0.3 0.20
(7.13) 9

−0.10

0.45

−0.14

0.24

1 L
3

Superior medial 27.48
gyrus, anterior (8.45)
cingulate

28.34 0.8 0.06
(8.46) 1

−0.08

0.55

−0.04

0.71

1 R
4

Hippocampus

21.49
(11.85)

22.95 0.7 0.08
(9.31) 6

−0.02

0.89

0.22

0.07

1 L
5

Hippocampus

29.25
(15.00)

32.05 0.6 0.13
(14.63 5
)

−0.15

0.26

0.19

0.12

1 L
6

Parahippocampa 30.56
l, fusiform gyri (18.12)

33.52 0.7 0.12
(19.33 0
)

−0.22

0.08

−0.18

0.13

ASL blood flow values are ml/100 g/min.
SMA = supplementary motor area.
*p-Values derived from Welch’s t-test.
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**Pearson
***Mean

correlations between fMRI activation and ASL blood flow (within group).
(standard deviation).

Discussion
In this study, we investigated the longitudinal trajectory of
semantic memory activation over a 5-year period among APOE ε4
carriers and non-carriers. At baseline, the non-carrier group showed
uniformly lower task-related activation during the semantic memory
paradigm compared to the APOE ε4 carriers. Over the 5-year interval,
however, functional activation steadily decreased in multiple regions of
interest in the APOE ε4 carriers, particularly in posterior cortical areas
commonly associated with the default mode network (Raichle et al.,
2001). In contrast, the non-carrier group demonstrated a consistent
increase in activation in the same regions over the same time frame.
Overall, our results provided evidence in support of differential
longitudinal trajectories for task-related brain activation as a function
of genetic risk for development of AD. The findings provide support for
the STAC-r theory that attempts to account for differences in the
trajectory of neural compensatory scaffolding associated with changes
in cognitive performance over time (Reuter-Lorenz and Park, 2014).
Our study illustrated the differential trajectories associated with
episodic memory performance, hippocampal volume, and fMRI
activation. At baseline, APOE ε4 carriers demonstrate elevated
functional activation at an earlier stage than non-carriers to
compensate presumably for accelerated accumulation of neural
pathology, likely related to AD pathology and possibly neurovascular
risk factors (see below). The progressive decline in functional
activation over time reflects reduced compensatory scaffolding
associated with age-inappropriate episodic memory decline and
accumulated AD-related pathology as reflected by atrophy of the
hippocampus. In contrast, APOE ε4 non-carriers demonstrated a
gradual increase in compensatory task-related brain activation over
time in the context of age-appropriate changes in episodic memory
and hippocampal volume, consistent with what would be expected
based on prior cross-sectional studies (Bangen et al., 2012; Grady,
2008; Nielson et al., 2002, 2006).
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The STAC-r model infers that compensatory activation
responses are predominantly associated with dorsolateral frontal
regions. This conclusion is derived primarily from fMRI studies that use
effortful, mostly episodic memory, tasks that engage dorsolateral
frontal regions. In contrast, we have demonstrated in a series of
studies (Douville et al., 2005; Nielson et al., 2006, 2010; Seidenberg
et al., 2009; Smith et al., 2011; Woodard et al., 2009, 2010) that
compensatory brain activation can occur within non-frontal brain
regions using the Famous Name Recognition Task, a low effort, high
accuracy semantic memory task. As noted by Binder et al. (2009),
there is considerable overlap between the semantic system and the
default mode network (DMN), whose primary brain regions
(hippocampus, posterior cingulate, temporoparietal junction, medial
frontal) are particularly vulnerable to early AD-related
neuropathological changes (Buckner, 2004). Our results suggest that
the STAC-r model should be generalized to include compensatory
processes occurring outside dorsolateral prefrontal regions.
To our knowledge, there have been no other longitudinal fMRI
studies comparing cognitively intact older individuals with varying
genetic risks for AD. However, one study (Smith et al., 2005)
examined middle-aged women (mean ages = 53 and 54) divided into
two groups: high genetic risk based on a positive family history of AD
and possession of an APOE ε4 allele (n=14) and low risk (n=10).
Changes in brain activation in response to a covert object-naming task
were measured at baseline and at four-year follow-up. The high risk
group did not demonstrate greater activation than the low risk group
at baseline, but showed a greater reduction in brain activation over
time. These results are difficult to interpret since the covert task used
in the Smith et al. study yielded no behavioral data to verify that
participants were in fact performing the task. A decline in activation
may readily be explained by a lack of task compliance during the
follow-up scan session. In contrast, the FNRT used in this study was
performed at a high level of performance at all three scan sessions.
The APOE ε4 carriers demonstrated a longitudinal decline in
performance on the RAVLT Delayed Recall measure (see Table 2 and
Fig. 1), whereas the non-carriers’ performance remained intact and
stable across the five year interval. We did not expect to see
performance changes in the Famous Name Recognition Task, which
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was designed to be performed at greater than 85% accuracy, even in
patients with amnestic MCI (Woodard et al., 2009). It is important to
note that most fMRI studies of normal aging employ effortful episodic
memory tasks whose performance declines with age. It is exceedingly
difficult to interpret longitudinal fMRI activation maps when task
performance is also declining. A brain map generated from an
individual performing at near chance levels will invariably be different
from a person performing well above chance. Removing incorrect trials
does not entirely correct the problem because the resulting brain maps
are generated from a sparse number of correct trials in individuals
performing near chance. Moreover, the BOLD signals that result from
greater task difficulty or effort in the poor performing group will be
inseparable from activation related to memory retrieval-related
processes, thus confounding any sound interpretation of the activation
maps (Hantke et al., 2013).
The APOE ε4 allele is present in approximately 20% of the
general population (Eichner et al., 2002) and 50% of patients
diagnosed with AD (Ward et al., 2012). Implicit in our study is the
assumption that a larger percentage of our APOE ε4 carriers will have
developed AD-related pathology over the course of the 5-year followup period than the percentage of non-carriers. Although none of our
participants met the criteria for AD at 5 years, 8 of 24 APOE ε4 carriers
(33.3%) converted to MCI, whereas only one non-carrier (4.8%)
converted (p=0.027). To appreciate these results, it is important to
emphasize that all of our participants were cognitively intact at study
entry. Long-term prospective studies suggest that the majority of the
study participants meeting the criteria for MCI will eventually convert
to AD (Petersen et al., 1999). It is conceivable that additional APOE ε4
carriers will convert to MCI/AD if examined over a longer follow-up
interval. The statistically higher percentage of MCI converters among
the carrier group supports our assumption that our APOE ε4
participants were more likely to be acquiring AD-related pathology
than non-carriers.
One may speculate as to the neuropathological processes that
result in increased compensatory scaffolding in APOE ε4 carriers at an
earlier age than non-carriers, followed by diminished scaffolding as
cognitive performance declines and hippocampal volumes diminish.
Plausible theories suggest that ε4 disrupts lipid homeostasis, amyloid
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precursor protein function, and the handling of brain amyloid,
cholinergic function, and neuroinflammation (Lane and Farlow, 2005;
Poirier, 2000). Our studies (Smith et al., 2011, 2014) and those of
others (Head et al., 2012) suggest that the negative effects of
possessing an ε4 allele on functional and structural imaging may be
offset by the positive effects of physical activity. Additional work is
needed to identify the precise mechanisms that underlie the trajectory
of neural compensation in APOE ε4 carriers.
It is also possible that the fMRI results could be affected by
changes in neurovascular coupling associated with AD pathology,
which is presumed to be greater in the APOE ε4 carriers. Our ASL
measurements of resting cerebral blood flow at the 5-year follow-up
session did not reveal group differences in any of the fROIs.
Furthermore, blood flow did not correlate with fMRI activation in any of
the fROIs after correction for multiple comparisons. Finally, it is
possible that our results were related to brain atrophy. However, the
rate of change in cortical thickness did not differ between the carrier
and non-carrier groups in any of the fROIs.
Within the Low Risk group, unexpected positive slopes were
observed for cortical thickness in the right and left fusiform/lingual gyri
and the left superior medial gyrus/anterior cingulate. Similar findings,
however, have been reported in prior neuroimaging studies of normal
aging. Thambisetty et al. (2010) observed significant longitudinal
increases in cortical thickness within the left fusiform and lingual gyri.
Similarly, Salat et al. (2004) observed increases in cortical thickness
within medial frontal regions, including the anterior cingulate. These
increases have been attributed to decreases in gray/white matter
contrast during aging (Thambisetty et al., 2010) and signal dropout
and anatomical distortions at the base of the brain (Salat et al., 2004).
Both explanations could potentially lead to distortions in regionallyspecific estimates of cortical thickness.
In our task-activated fMRI analyses, we chose not to control for
age since the two groups did not differ statistically in mean age.
Nevertheless, we conducted a supplementary analysis in which agecorrected residual scores were generated for the mean fMRI signal
change for each fROI, participant, and time period and then repeated
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the LME analyses. Notably, none of the intercept and slope results
reported in Table 3 changed statistically.
The current study has its limitations. It is possible that the
subset of participants who completed all three examination sessions
are not representative of the entire sample of participants enrolled into
this longitudinal study. We were unable to identify, however, any
demographic or baseline neuropsychological or neuroimaging variables
that differentiated participants who completed the study versus those
who did not. This study did not use any other imaging biomarkers to
measure AD-related pathology, such as CSF analyses of tau and
amyloid proteins or amyloid deposition using PET imaging. The ASL
measurement of perfusion was only conducted at the 5-year follow-up.
Finally, the relatively small number of APOE ε4 carriers who converted
to MCI limited our ability to conduct post-hoc imaging analyses
comparing converters to non-converters.

Conclusions
Compensatory brain activation is commonly seen in the fMRI
scans of cognitively intact elders. We have demonstrated that this
compensatory response is accelerated in cognitively intact individuals
at genetic risk for AD and declines precipitously once cognitive
dysfunction and hippocampal atrophy become apparent. In contrast,
elders with a lower risk of developing AD and age-appropriate
cognition employ increased brain activation to maintain functionality;
this compensatory response increases with age as long as the low risk
individual continues to demonstrate age-appropriate cognition. Our
fMRI results could not be attributed to changes in task performance,
group differences in cerebral perfusion, or regional cortical atrophy.
The results provide prospective, empirical evidence of differential
longitudinal trajectories based on AD risk, supporting the theoretical
propositions underlying the STAC-r neural compensation theory
(Reuter-Lorenz and Park, 2014).
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